| Type | Public (NASDAQ: ARNA) |
|---|---|
| Industry | Biotechnology |
| Headquarters | San Diego, California, USA |
| Key people | Jack Lief, cofounder and CEO Dominic Behan, co-founder and senior scientist |
| Products | in development |
| Revenue | US$10.4M (FY 2009)[1] |
| Operating income | US$-138M (FY 2009)[1] |
| Net income | US$-153M (FY 2009)[1] |
| Total assets | US$236M (FY 2009)[2] |
| Total equity | US$74.6M (FY 2009)[2] |
| Website | www.arenapharm.com |
Arena Pharmaceuticals, Inc. is a biopharmaceutical company located in San Diego, California. The company is developing oral medications that target G-protein-coupled receptors. Currently none of the drugs is approved by the U.S. Food and Drug Administration, but several are in Phase I to III testing, namely (stand January 2009):